secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vir Biotechnology, Inc. (VIR)
CIK:        0001706431
Form:       8-K
Filed at:   2023-03-08T23:59:59+00:00
Accession:  0001193125-23-064485
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vir Biotechnology amends bylaws with enhanced stockholder nomination requirements and procedural updates
--------------------------------------------------------------------------------

- Eliminated requirement to make stockholder list available at meeting; added adjournment for technical failure.
- Enhanced disclosure requirements for stockholder nominations and proposals, including Rule 14a-19 compliance.
- Non-compliance with Rule 14a-19 may result in disregarding nominees and votes.
- Added emergency bylaw provision for director and officer authority during crises.
- Other technical, conforming, and clarifying changes made to reflect Delaware law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523064485/0001193125-23-064485-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1706431/000119312523064485/d478454d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-064485

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer